Suchergebnisse - "Grunewald, Tami"

PubPharm (9)

1

Self-supervised deep learning for highly efficient spatial immunophenotyping

enthalten in: EBioMedicine | 2023

von Zhang, H. | AbdulJabbar, K. | Grunewald, T. | +13

2

Self-supervised Antigen Detection Artificial Intelligence (SANDI)

enthalten in: Resource-efficient medical image analysis | 2022

von Zhang, H. | AbdulJabbar, K. | Grunewald, T. | +11

3

Neutropenic sepsis rates in patients receiving bleomycin, etoposide and cisplatin chemotherapy using olanzapine and reduced doses of dexamethasone compared to a standard antiemetic regimen

enthalten in: BJU international | 2021

von Gjafa, E. | Ng, K. | Grunewald, T. | +5

4

Neutropenic sepsis rates in patients receiving bleomycin, etoposide and cisplatin chemotherapy using olanzapine and reduced doses of dexamethasone compared to a standard antiemetic regimen

enthalten in: BJU International | 2021

von Gjafa, E. | Ng, K. | Grunewald, T. | +5

5

Targeted Therapies for Ovarian Cancer

enthalten in: Best practice & research. Clinical obstetrics & gynaecology | 2017

von Grunewald, T. | Ledermann, J.

6

Targeted Therapies for Ovarian Cancer

enthalten in: Best practice & research / Clinical obstetrics & gynaecology | 2017

von Grunewald, T. | Ledermann, J.

7

Targeted Therapies for Ovarian Cancer

enthalten in: Best practice & research / Clinical obstetrics & gynaecology | 2016

von Grunewald, T. | Ledermann, J.

8

Impact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer : analysis of the CALYPSO trial

enthalten in: Gynecologic oncology | 2015

von Lee, C. | Lord, S. | Grunewald, T. | +12

9

Impact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer: analysis of the CALYPSO trial

enthalten in: Gynecologic oncology | 2015

von Lee, C. | Lord, S. | Grunewald, T. | +12

1
[1]